Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The mechanisms underlying the chronicity of autoimmune diseases of the central nervous system (CNS) are largely unknown. In particular, it is unclear whether tissue-resident memory T cells (TRM) contribute to lesion pathogenesis during chronic CNS autoimmunity. Here, we observed that a high frequency of brain-infiltrating CD8+ T cells exhibit a TRM-like phenotype in human autoimmune encephalitis. Using mouse models of neuronal autoimmunity and a combination of T single-cell transcriptomics, high-dimensional flow cytometry, and histopathology, we found that pathogenic CD8+ T cells behind the blood-brain barrier adopt a characteristic TRM differentiation program, and we revealed their phenotypic and functional heterogeneity. In the diseased CNS, autoreactive tissue-resident CD8+ T cells sustained focal neuroinflammation and progressive loss of neurons, independently of recirculating CD8+ T cells. Consistently, a large fraction of autoreactive tissue-resident CD8+ T cells exhibited proliferative potential as well as proinflammatory and cytotoxic properties. Persistence of tissue-resident CD8+ T cells in the CNS and their functional output, but not their initial differentiation, were crucially dependent on CD4+ T cells. Collectively, our results point to tissue-resident CD8+ T cells as essential drivers of chronic CNS autoimmunity and suggest that therapies targeting this compartmentalized autoreactive T cell subset might be effective for treating CNS autoimmune diseases. Descrip…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animal and in-vitro studies demonstrate that inflammatory stimuli may initiate long-term priming of the microglia, peripheral CD4+ and CD8+ T cells to a proinflammatory state, (352-354) potentially increasing amyloid plaque deposition.(355)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [353]
Citations
Cites
Fast gene set enrichment analysis
Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,454
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Levine, J. H., Simonds, E. F., Bendall, S. C., Davis, K. L., Amir, E.-A. D., Tadmor, M. D., Litvin, O., Fienberg, H. G., Jager, A., Zunder, E. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.047 · Cited by 2,303 · cited 2×
“Supplementary Materials Figures S1 – S8 Tables S1 – S3 Datafile S1 References (45-49)”
BackgroundAntibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329 · cited 1×
“INTRODUCTION Chronic autoimmune diseases of the central nervous system (CNS) can target different CNS-resident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune encep…”
BackgroundMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Alfei, F., Kanev, K., Hofmann, M., Wu, M., Ghoneim, H. E., Roelli, P., Utzschneider, D. T., von Hoesslin, M., Cullen, J. G., Fan, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1326-9 · Cited by 899
Self-citationThe movers and shapers in immune privilege of the CNS
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017) · Nature Immunology · doi:10.1038/ni.3666 · Cited by 893 · cited 1×
“The concept of the immune privilege of the CNS has been challenged by the identification of several gateways between the peripheral immune system and the brain, despite the restrictive blood-brain barrier (34, 35).”
BackgroundT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866 · cited 1×
“An autoimmune process also appears at play in prevalent neurodegenerative disorders such as Parkinson’s disease (6).”
BackgroundAnalysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712 · cited 1×
“There is evidence that antigenic persistence is a key parameter for chronic inflammation and complete destruction of the cellular targets often results in subsiding of local inflammation (5, 7, 8).”
BackgroundImmunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Self-citationTissue-Resident T Cells and Other Resident Leukocytes
Masopust, D., & Soerens, A. G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053214 · Cited by 608
Wakim, L. M., Woodward-Davis, A., & Bevan, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010201107 · Cited by 575 · cited 1×
“TRM have been involved in pathogen clearance and/or in the control of pathogen reactivation in infectious diseases of the CNS (31, 32, 37, 38).”
BackgroundDoering, T. A., Crawford, A., Angelosanto, J. M., Paley, M. A., Ziegler, C. G., & Wherry, E. J. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.021 · Cited by 548
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548 · cited 3×
“Indeed, although TRM-like cells have been reported in the active lesions of MS patients (10, 23), and in”
BackgroundSelf-citationTissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406 · cited 1×
“The presence of TRM has now been documented in tissues other than barrier tissues, such as the CNS (16, 17), and in conditions as diverse as cancer, graft-versus-host disease, allergy, and autoimmunity (13, 18-21).”
BackgroundThe Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain
Wakim, L. M., Woodward-Davis, A., Liu, R., Hu, Y., Villadangos, J., Smyth, G., & Bevan, M. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201305 · Cited by 363 · cited 1×
“Gene set enrichment analysis (GSEA) further confirmed that the transcriptome of HA-specific hypothalamic CD8 T cells in comparison to their splenic counterparts is strongly enriched for a previously published brain TRM gene signature (27) (Fig.”
BackgroundAlves de Lima, K., Rustenhoven, J., & Kipnis, J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102319-103410 · Cited by 348
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 343
Parsing the interferon transcriptional network and its disease associations
Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., Raj, T., Ye, C. J., Chevrier, N., Zhang, S.-Y., Feng, T., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.032 · Cited by 337
Kapoor, R., Ho, P.-R., Campbell, N., Chang, I., Deykin, A., Forrestal, F., Lucas, N., Yu, B., Arnold, D. L., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30069-3 · Cited by 333
Immunology of Relapse and Remission in Multiple Sclerosis
Steinman, L. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120227 · Cited by 330 · cited 1×
“4 Introduction Chronic autoimmune diseases of the central nervous system (CNS) can target different CNSresident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune ence…”
BackgroundCao, Y., Goods, B. A., Raddassi, K., Nepom, G. T., Kwok, W. W., Love, J. C., & Hafler, D. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8038 · Cited by 295 · cited 1×
“4 Introduction Chronic autoimmune diseases of the central nervous system (CNS) can target different CNSresident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune ence…”
BackgroundInterleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma
Hondowicz, B. D., An, D., Schenkel, J. M., Kim, K. S., Steach, H. R., Krishnamurty, A. T., Keitany, G. J., Garza, E. N., Fraser, K. A., Moon, J. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.004 · Cited by 293
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Palanichamy, A., Jahn, S., Nickles, D., Derstine, M., Abounasr, A., Hauser, S. L., Baranzini, S. E., Leppert, D., & von Büdingen, H.-C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400118 · Cited by 289
Milner, J. J., Toma, C., He, Z., Kurd, N. S., Nguyen, Q. P., McDonald, B., Quezada, L., Widjaja, C. E., Witherden, D. A., Crowl, J. T., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.007 · Cited by 271 · cited 1×
“With the recent advance in single-cell transcriptome profiling, it has becoming clearer that TRM form a heterogeneous T cell pool and that the residency program does not prevent T cells from acquiring specialization programs (44).”
BackgroundCD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267
Zundler, S., Becker, E., Spocinska, M., Slawik, M., Parga-Vidal, L., Stark, R., Wiendl, M., Atreya, R., Rath, T., Leppkes, M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0298-5 · Cited by 239 · cited 1×
“In chronic inflammatory/autoimmune diseases, such as asthma, psoriasis, vitiligo, inflammatory bowel disease, and type 1 diabetes, TRM have been identified in the affected tissue in animal models and/or human conditions (19, 21, 22).”
BackgroundFransen, N. L., Hsiao, C.-C., van der Poel, M., Engelenburg, H. J., Verdaasdonk, K., Vincenten, M. C. J., Remmerswaal, E. B. M., Kuhlmann, T., Mason, M. R. J., Hamann, J., et al. (2020) · Brain · doi:10.1093/brain/awaa117 · Cited by 229
Tissue-resident memory T cells in tumor immunity and immunotherapy
Okła, K., Farber, D. L., & Zou, W. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201605 · Cited by 228 · cited 1×
“The presence of TRM has now been documented in tissues other than barrier tissues, such as the CNS (16, 17), and in conditions as diverse as cancer, graft-versus-host disease, allergy, and autoimmunity (13, 18-21).”
BackgroundBrain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection
Steinbach, K., Vincenti, I., Kreutzfeldt, M., Page, N., Muschaweckh, A., Wagner, I., Drexler, I., Pinschewer, D., Korn, T., & Merkler, D. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151916 · Cited by 213
Self-citationSon, Y. M., Cheon, I. S., Wu, Y., Li, C., Wang, Z., Gao, X., Chen, Y., Takahashi, Y., Fu, Y.-X., Dent, A. L., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abb6852 · Cited by 209
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy
Liblau, R. S., Vassalli, A., Seifinejad, A., & Tafti, M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70218-2 · Cited by 187 · cited 2×
“INTRODUCTION Chronic autoimmune diseases of the central nervous system (CNS) can target different CNS-resident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune encep…”
BackgroundSelf-citationCD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice
Bernard-Valnet, R., Yshii, L., Quériault, C., Nguyen, X.-H., Arthaud, S., Rodrigues, M., Canivet, A., Morel, A.-L., Matthys, A., Bauer, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603325113 · Cited by 143
Self-citationTranscriptomic and clonal characterization of T cells in the human central nervous system
Pappalardo, J. L., Zhang, L., Pecsok, M. K., Perlman, K., Zografou, C., Raddassi, K., Abulaban, A., Krishnaswamy, S., Antel, J., van Dijk, D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb8786 · Cited by 137
Resident Memory T Cells in Autoimmune Skin Diseases
Ryan, G. E., Harris, J. E., & Richmond, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652191 · Cited by 132
Low, J. S., Farsakoglu, Y., Amezcua Vesely, M. C., Sefik, E., Kelly, J. B., Harman, C. C. D., Jackson, R., Shyer, J. A., Jiang, X., Cauley, L. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192291 · Cited by 120 · cited 6×
“As local cognate antigen expression has been shown to be an important mechanism of TRM maintenance within the tissues (28, 29), we assessed whether HA-specific tissue-resident CD8 T cells were proliferating locally.”
BackgroundInfluentialEarly adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis
Beltrán, E., Gerdes, L. A., Hansen, J., Flierl-Hecht, A., Krebs, S., Blum, H., Ertl-Wagner, B., Barkhof, F., Kümpfel, T., Hohlfeld, R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128475 · Cited by 119
A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool
Kok, L., Dijkgraaf, F. E., Urbanus, J., Bresser, K., Vredevoogd, D. W., Cardoso, R. F., Perié, L., Beltman, J. B., & Schumacher, T. N. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191711 · Cited by 114 · cited 1×
“A recent report has detected, among the pool of peripheral memory precursor cells, precursors of TRM, which exhibit an increased ability to form de novo TRM (40).”
BackgroundLong-term maintenance of lung resident memory T cells is mediated by persistent antigen
Uddback, I. E. M., Cartwright, E. K., Schøller, A. S., Wein, A. N., Hayward, S. L., Lobby, J. L., Takamura, S., Thomsen, A. R., Kohlmeier, J. E., & Christensen, J. P. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0309-3 · Cited by 111 · cited 1×
“As local cognate antigen expression has been shown to be an important mechanism of TRM maintenance within the tissues (28, 29), we assessed whether HA-specific tissue-resident CD8 T cells were proliferating locally.”
BackgroundKuric, E., Seiron, P., Krogvold, L., Edwin, B., Buanes, T., Hanssen, K. F., Skog, O., Dahl-Jørgensen, K., & Korsgren, O. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.11.002 · Cited by 80
Sagan, S. A., Winger, R. C., Cruz-Herranz, A., Nelson, P. A., Hagberg, S., Miller, C. N., Spencer, C. M., Ho, P. P., Bennett, J. L., Levy, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617859114 · Cited by 79 · cited 1×
“4 Introduction Chronic autoimmune diseases of the central nervous system (CNS) can target different CNSresident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune ence…”
BackgroundVincenti, I., Page, N., Steinbach, K., Yermanos, A., Lemeille, S., Nunez, N., Kreutzfeldt, M., Klimek, B., Di Liberto, G., Egervari, K., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6058 · Cited by 70
Self-citationImmunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications
Yshii, L., Bost, C., & Liblau, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00991 · Cited by 66 · cited 2×
“In these conditions, CD8 T cells are likely responsible for neuronal damage, which can be widespread or very selective (8, 25).”
BackgroundSelf-citationRen, H. M., Kolawole, E. M., Ren, M., Jin, G., Netherby-Winslow, C. S., Wade, Q., Shwetank, Rahman, Z. S. M., Evavold, B. D., & Lukacher, A. E. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5590 · Cited by 64
Hsiao, C., Fransen, N. L., van den Bosch, A. M. R., Brandwijk, K. I. M., Huitinga, I., Hamann, J., & Smolders, J. (2020) · European Journal of Immunology · doi:10.1002/eji.202048665 · Cited by 47
Yermanos, A., Agrafiotis, A., Kuhn, R., Robbiani, D., Yates, J., Papadopoulou, C., Han, J., Sandu, I., Weber, C. R., Bieberich, F., et al. (2021) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqab023 · Cited by 45
Self-citationvan Gisbergen, K. P. J. M., Zens, K. D., & Münz, C. (2021) · European Journal of Immunology · doi:10.1002/eji.202049062 · Cited by 39
Mockus, T. E., Shwetank, Lauver, M. D., Ren, H. M., Netherby, C. S., Salameh, T., Kawasawa, Y. I., Yue, F., Broach, J. R., & Lukacher, A. E. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007365 · Cited by 38
Bernard‐Valnet, R., Frieser, D., Nguyen, X., Khajavi, L., Queriault, C., Arthaud, S., Melzi, S., Fusade-Boyer, M., Masson, F., Zytnicki, M., et al. (2021) · Brain · doi:10.1093/brain/awab455 · Cited by 38 · cited 3×
“We interrogated our recent transcriptome analysis (bulk RNAseq) performed at day 14 after vaccination (30) and confirmed that HA-specific CD8+ T cells infiltrating the hypothalamus adopted a TRM transcriptional program.”
InfluentialSelf-citationPersistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
Page, N., Lemeille, S., Vincenti, I., Klimek, B., Mariotte, A., Wagner, I., Di Liberto, G., Kaye, J., & Merkler, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21109-3 · Cited by 34 · cited 1×
“TRM have been involved in pathogen clearance and/or in the control of pathogen reactivation in infectious diseases of the CNS (31, 32, 37, 38).”
BackgroundSelf-citationDecoding Tissue-Residency: Programming and Potential of Frontline Memory T Cells
Park, S. L., & Mackay, L. K. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037960 · Cited by 21
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati, M., Wheeler, M. A., Weiner, H. L., & Quintana, F. J. (2023) · Cell · doi:10.1016/j.cell.2023.03.008 · Cited by 222
The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases
Tsuji, A., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T. T., & Matsuda, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065742 · Cited by 178
“Furthermore, the AHR could modify the differentiation and function of both CD4+ T cells and CD8+ T cells [97], which might be involved in chronic autoimmune damage to CNS neurons [98] (Figure 2).”
BackgroundThe Multifaceted Role of Tissue-Resident Memory T Cells
Christo, S. N., Park, S. L., Mueller, S. N., & Mackay, L. K. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-020220 · Cited by 154
Tröscher, A. R., Mair, K. M., de Juan, L. V., Köck, U., Steinmaurer, A., Baier, H., Becker, A. J., Blümcke, I., Finzel, M., Geis, C., et al. (2022) · Brain · doi:10.1093/brain/awac404 · Cited by 96
“This was also demonstrated recently in a CD8-mediated translational model for paraneoplastic encephalitis.(56) Second, PD-1 is involved in negative regulation of autoimmune reactions.”
BackgroundSelf-citation
Metadata
- Authors
- Frieser, D., Pignata, A., Khajavi, L., Shlesinger, D., Gonzalez-Fierro, C., Nguyen, X.-H., Yermanos, A., Merkler, D., Höftberger, R., Desestret, V., Mair, K. M., Bauer, J., Masson, F., & Liblau, R. S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ETH Zurich (CH)
- University of Geneva (CH)
- Medical University of Vienna (AT)
- Lyon 1 Université (FR)
- Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.
- Corresponding author
- Liblau, Roland S.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2022-04-13
- Volume
- 14
- Issue
- 640
- Pages
- eabl6157-eabl6157
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4224029197
- Cited by
- 102
- References
- 50
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 26 · 2023: 18 · 2022: 11
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-18-RAR3-0003, ANR-18-RHUS-0012)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tissue-resident memory T cells, CD8+ T cells, central nervous system autoimmunity, autoimmune encephalitis, blood-brain barrier, neuroinflammation, neuronal loss, CD4+ T cell help, T cell heterogeneity, autoimmune disease therapy
- MeSH terms
- Animals, Autoimmune Diseases, Central Nervous System, Immunologic Memory, Neurons, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.